Current Trends in Vascular Biomarkers for Systemic Sclerosis: A Narrative Review
International Journal of Molecular Sciences · 17.02.2023 · 24 (4) · 4097
DOI: 10.3390/ijms24044097 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 17.02.2023. Verfasst von Bianca Saveria Fioretto und 4 weiteren Autor:innen. Beteiligte Einrichtung: Section of Anatomy and Histology, Department of Experimental and Clinical Medicine, University of Florence, 50134 Florence, Italy. Hauptthemen laut MEDLINE: Scleroderma, Systemic, Vascular Diseases. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 269 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Systemic sclerosis (SSc, scleroderma) is a multifaceted rare connective tissue disease whose pathogenesis is dominated by immune dysregulation, small vessel vasculopathy, impaired angiogenesis, and both cutaneous and visceral fibrosis. Microvascular impairment represents the initial event of the disease, preceding fibrosis by months or years and accounting for the main disabling and/or life-threatening clinical manifestations, including telangiectasias, pitting scars, periungual microvascular abnormalities (e.g., giant capillaries, hemorrhages, avascular areas, ramified/bushy capillaries) clinically detectable by nailfold videocapillaroscopy, ischemic digital ulcers, pulmonary arterial hypertension, and scleroderma renal crisis. Despite a variety of available treatment options, treatment of SSc-related vascular disease remains problematic, even considering SSc etherogenity and the quite narrow therapeutic window. In this context, plenty of studies have highlighted the great usefulness in clinical practice of vascular biomarkers allowing clinicians to assess the evolution of the pathological process affecting the vessels, as well as to predict the prognosis and the response to therapy. The current narrative review provides an up-to-date overview of the main candidate vascular biomarkers that have been proposed for SSc, focusing on their main reported associations with characteristic clinical vascular features of the disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section of Anatomy and Histology, Department of Experimental and Clinical Medicine, University of Florence, 50134 Florence, Italy.
- Section of Internal Medicine, Department of Experimental and Clinical Medicine, University of Florence, 50134 Florence, Italy.
- Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), IRCCS San Raffaele Hospital, 20132 Milan, Italy.
- Imaging Platform, Department of Experimental and Clinical Medicine, University of Florence, 50134 Florence, Italy.
ORCID-Profile: Bianca Saveria Fioretto, Irene Rosa, Eloisa Romano, Mirko Manetti
Zitieren
APA
Fioretto, B. S., Rosa, I., Matucci-Cerinic, M., Romano, E., & Manetti, M. (2023). Current Trends in Vascular Biomarkers for Systemic Sclerosis: A Narrative Review. International Journal of Molecular Sciences, 24(4), 4097. https://doi.org/10.3390/ijms24044097
Vancouver
Fioretto BS, Rosa I, Matucci-Cerinic M, Romano E, Manetti M. Current Trends in Vascular Biomarkers for Systemic Sclerosis: A Narrative Review. International Journal of Molecular Sciences. 2023;24(4):4097. doi:10.3390/ijms24044097
BibTeX
@article{Fioretto2023,
author = {Fioretto, Bianca Saveria and Rosa, Irene and Matucci-Cerinic, Marco and Romano, Eloisa and Manetti, Mirko},
title = {Current Trends in Vascular Biomarkers for Systemic Sclerosis: A Narrative Review},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {4},
pages = {4097},
doi = {10.3390/ijms24044097}
}
EUVIMED